447 related articles for article (PubMed ID: 28161579)
21. Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine.
Barrera J; Brake DA; Schutta C; Ettyreddy D; Kamicker BJ; Rasmussen MV; Bravo de Rueda C; Zurita M; Pisano M; Hurtle W; Brough DE; Butman BT; Harper BG; Neilan JG
Vaccine; 2018 Nov; 36(48):7345-7352. PubMed ID: 30327212
[TBL] [Abstract][Full Text] [Related]
22. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
Li X; Liu R; Tang H; Jin M; Chen H; Qian P
Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351
[TBL] [Abstract][Full Text] [Related]
23. Inclusion of a specific T cell epitope increases the protection conferred against foot-and-mouth disease virus in pigs by a linear peptide containing an immunodominant B cell site.
Cubillos C; de la Torre BG; Bárcena J; Andreu D; Sobrino F; Blanco E
Virol J; 2012 Mar; 9():66. PubMed ID: 22416886
[TBL] [Abstract][Full Text] [Related]
24. Protection of a novel epitope-RNA VLP double-effective VLP vaccine for foot-and-mouth disease.
Dong YM; Cai JC; Chen HT; Chen L
Antiviral Res; 2016 Oct; 134():108-116. PubMed ID: 27565990
[TBL] [Abstract][Full Text] [Related]
25. A Heat-Induced Mutation on VP1 of Foot-and-Mouth Disease Virus Serotype O Enhanced Capsid Stability and Immunogenicity.
Dong H; Lu Y; Zhang Y; Mu S; Wang N; Du P; Zhi X; Wen X; Wang X; Sun S; Zhang Y; Guo H
J Virol; 2021 Jul; 95(16):e0017721. PubMed ID: 34011545
[TBL] [Abstract][Full Text] [Related]
26. Indirect ELISA using a multi-epitope recombinant protein to detect antibodies against foot-and-mouth disease virus serotype O in pigs.
Cao Y; Zhou W; Xing X; Zhang J; Fu Y; Li K; Sun P; Li P; Bai X; Ma X; Bao H; Li D; Chen Y; Lu Z; Liu Z
J Virol Methods; 2018 Dec; 262():26-31. PubMed ID: 30244034
[TBL] [Abstract][Full Text] [Related]
27. Intra-serotype SAT2 chimeric foot-and-mouth disease vaccine protects cattle against FMDV challenge.
Maree FF; Nsamba P; Mutowembwa P; Rotherham LS; Esterhuysen J; Scott K
Vaccine; 2015 Jun; 33(25):2909-16. PubMed ID: 25930116
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep.
Singanallur NB; Pacheco JM; Arzt J; Stenfeldt C; Fosgate GT; Rodriguez L; Vosloo W
Antiviral Res; 2017 Sep; 145():114-122. PubMed ID: 28780422
[TBL] [Abstract][Full Text] [Related]
29. The immunopotentiator CVC1302 enhances immune efficacy and protective ability of foot-and-mouth disease virus vaccine in pigs.
Chen J; Yu X; Zheng Q; Hou L; Du L; Zhang Y; Qiao X; Hou J; Huang K
Vaccine; 2018 Dec; 36(52):7929-7935. PubMed ID: 30470640
[TBL] [Abstract][Full Text] [Related]
30. Chimeric virus-like particles elicit protective immunity against serotype O foot-and-mouth disease virus in guinea pigs.
Liu X; Fang Y; Zhou P; Lu Y; Zhang Q; Xiao S; Dong Z; Pan L; Lv J; Zhang Z; Zhang Y; Wang Y
Appl Microbiol Biotechnol; 2017 Jun; 101(12):4905-4914. PubMed ID: 28365796
[TBL] [Abstract][Full Text] [Related]
31. Development of Protective Immunity against Inactivated Iranian Isolate of Foot-and-Mouth Disease Virus Type O/IRN/2007 Using Gamma Ray-Irradiated Vaccine on BALB/c Mice and Guinea Pigs.
Motamedi-Sedeh F; Soleimanjahi H; Jalilian AR; Mahravani H; Shafaee K; Sotoodeh M; Taherkarami H; Jairani F
Intervirology; 2015; 58(3):190-6. PubMed ID: 26202581
[TBL] [Abstract][Full Text] [Related]
32. Comparative efficacy of virus like particle (VLP) vaccine of foot-and-mouth-disease virus (FMDV) type O adjuvanted with poly I:C or CpG in guinea pigs.
Terhuja M; Saravanan P; Tamilselvan RP
Biologicals; 2015 Nov; 43(6):437-43. PubMed ID: 26493006
[TBL] [Abstract][Full Text] [Related]
33. Coinjection of a vaccine and anti-viral agents can provide fast-acting protection from foot-and-mouth disease.
You SH; Kim T; Choi JH; Park G; Lee KN; Kim B; Lee MH; Kim HS; Kim SM; Park JH
Antiviral Res; 2017 Jul; 143():195-204. PubMed ID: 28454913
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a genetically modified foot-and-mouth disease virus vaccine candidate generated by reverse genetics.
Li P; Bai X; Sun P; Li D; Lu Z; Cao Y; Fu Y; Bao H; Chen Y; Xie B; Liu Z
BMC Vet Res; 2012 May; 8():57. PubMed ID: 22591597
[TBL] [Abstract][Full Text] [Related]
35. Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease.
Lu Z; Bao H; Cao Y; Sun P; Guo J; Li P; Bai X; Chen Y; Xie B; Li D; Liu Z; Xie Q
Vaccine; 2008 Dec; 26 Suppl 6():G48-53. PubMed ID: 19178894
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of a 3A-truncated foot-and-mouth disease virus in pigs for its potential as a marker vaccine.
Li P; Lu Z; Bai X; Li D; Sun P; Bao H; Fu Y; Cao Y; Chen Y; Xie B; Yin H; Liu Z
Vet Res; 2014 May; 45(1):51. PubMed ID: 24885414
[TBL] [Abstract][Full Text] [Related]
37. A bivalent B-cell epitope dendrimer peptide can confer long-lasting immunity in swine against foot-and-mouth disease.
Cañas-Arranz R; Forner M; Defaus S; Rodríguez-Pulido M; de León P; Torres E; Bustos MJ; Borrego B; Sáiz M; Blanco E; Andreu D; Sobrino F
Transbound Emerg Dis; 2020 Jul; 67(4):1614-1622. PubMed ID: 31994334
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with a FMDV O Mya98 lineage virus in pigs 4 and 7 days post vaccination.
Wilna V; Hong NT; Geoffrey FT; Jacqueline MM; Jianning W; Van Phuc K; Ngon QV; Phuong le TT; Hung D; Hanh TX; Van Hung V; Anh le TQ; Tien MT; Quang le TV; Long NT; Nagendrakumar SB
Vaccine; 2015 Jun; 33(24):2778-85. PubMed ID: 25917677
[TBL] [Abstract][Full Text] [Related]
39. Protective immune response against foot-and-mouth disease virus challenge in guinea pigs vaccinated with recombinant P1 polyprotein expressed in Pichia pastoris.
Balamurugan V; Renji R; Venkatesh G; Reddy GR; Nair SP; Ganesh K; Suryanarayana VV
Arch Virol; 2005 May; 150(5):967-79. PubMed ID: 15662485
[TBL] [Abstract][Full Text] [Related]
40. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs.
Du Y; Dai J; Li Y; Li C; Qi J; Duan S; Jiang P
Vet Immunol Immunopathol; 2008 Aug; 124(3-4):274-83. PubMed ID: 18511133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
